<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25797" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neurilemmoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davis</surname>
            <given-names>Donald D.</given-names>
          </name>
          <aff>Wellstar Atlanta Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kane</surname>
            <given-names>Steven M.</given-names>
          </name>
          <aff>Wellstar Atlanta Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Donald Davis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Steven Kane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25797.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The vast majority of tumors of the peripheral nervous system arise from the cells of Schwann, rather than from the nerve cells themselves. Schwann cells, or neurilemma, are cells that are responsible for the production of the myelin sheath around neuronal axons. This activity reviews the presentation, pathogenesis, and management of patients presenting with neurilemmomas. We examine the complications and briefly explore the impact of the disorder on patients and highlight the importance of an interdisciplinary approach to treat these individuals appropriately.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the most frequent presentation of neurilemmomas.</p></list-item><list-item><p>Summarize the pathophysiology of neurilemmomas.</p></list-item><list-item><p>Explain the management of neurilemmomas.</p></list-item><list-item><p>Explain the role of the interprofessional team in optimizing the management of neurilemmomas.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25797&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25797">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25797.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The vast majority of tumors of the peripheral nervous system arise from the cells of Schwann, rather than from the nerve cells themselves.&#x000a0; Schwann cells, or neurilemma, are cells that are responsible for the production of the myelin sheath around neuronal axons. Most of these tumors are benign and designated as "schwannomas" or "neurilemmomas," and may appear spontaneously as solitary lesions, or as part of an underlying clinical condition such as neurofibromatosis. These vast majority of these tumors are&#x000a0;slow-growing, encapsulated tumors of these Schwann cells within a collagenous&#x000a0;matrix.</p>
      </sec>
      <sec id="article-25797.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Neurilemmomas&#x000a0;arise from the cells of Schwann and may occur spontaneously, or in conjunction with clinical syndromes such as neurofibromatosis type 2, Schwannomatosis, and Carney complex.<xref ref-type="bibr" rid="article-25797.r1">[1]</xref></p>
      </sec>
      <sec id="article-25797.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Vestibular neurilemmomas were found to have an incidence ranging from 0.01% to 0.1% in the general population with a peak age of 20 to 50, without a clear preference for sex.<xref ref-type="bibr" rid="article-25797.r2">[2]</xref> In an autopsy study of elderly patients with neurofibromatosis type 2, the incidence of sporadic central schwannoma was found to be much higher at 4.5%.<xref ref-type="bibr" rid="article-25797.r1">[1]</xref><xref ref-type="bibr" rid="article-25797.r3">[3]</xref><xref ref-type="bibr" rid="article-25797.r4">[4]</xref><xref ref-type="bibr" rid="article-25797.r5">[5]</xref><xref ref-type="bibr" rid="article-25797.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25797.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologic examination of the well-circumscribed neurilemmoma shows degenerative changes and a variable presentation of compact spindles, referred to as "Antoni A" bodies and microcystic areas with a high concentration of macrophages and collagen fibers, designated as "Antoni B" bodies. Additionally, nuclear palisading around cell bodies is described as Verocay bodies and is strongly suggestive of neurilemmomas. Schwannomas classically stain strongly for S100 protein expression on immunohistochemistry and will have pericellular type IV collagen in abundance. Glial fibrillary acid protein (GFAP), podoplanin, calretinin, and SOX10 may be present in varying degrees within different subtypes of neurilemmomas.<xref ref-type="bibr" rid="article-25797.r7">[7]</xref><xref ref-type="bibr" rid="article-25797.r8">[8]</xref><xref ref-type="bibr" rid="article-25797.r9">[9]</xref><xref ref-type="bibr" rid="article-25797.r10">[10]</xref></p>
      </sec>
      <sec id="article-25797.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with a neurilemmoma typically present with an asymptomatic mass but may experience pain and paresthesias throughout the distribution of the entire nerve as the tumor grows larger and applies pressure to the nerve. Neurilemmomas of the posterior spinal nerve will produce sensory symptomatology, while compression of the anterior spinal nerves may produce motor deficits.</p>
        <p>On physical exam, physicians may notice a palpable mass that can be mobilized in the plane orthogonal to the axis of the affected nerve, but not longitudinally aligned with the affected nerve.&#x000a0;</p>
        <p>Neurilemmomas most frequently occur in the neck and mediastinum, and when present in the extremities are far more common along the flexor surfaces.<xref ref-type="bibr" rid="article-25797.r1">[1]</xref><xref ref-type="bibr" rid="article-25797.r11">[11]</xref></p>
      </sec>
      <sec id="article-25797.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>On CT scans, neurilemmomas are hypodense compared to muscle and enhance with contrast.&#x000a0;On MRI, neurilemmomas are isointense to muscle on T1-weighted imaging and bright on T2-weighted imaging with occasional low signal cysts. While inconsistent, the best way to distinguish a neurilemmoma from a neurofibroma is an eccentric displacement of the nerve and heterogeneous appearance with cystic degeneration, suggestive of a schwannoma.<xref ref-type="bibr" rid="article-25797.r2">[2]</xref><xref ref-type="bibr" rid="article-25797.r12">[12]</xref></p>
        <p>Biopsy of the&#x000a0;neoplasm,&#x000a0;as discussed above, is the best way to confirm a diagnosis of a schwannoma, with a defined fibrous capsule and Antoni A and Antoni B bodies on histology.<xref ref-type="bibr" rid="article-25797.r13">[13]</xref></p>
      </sec>
      <sec id="article-25797.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Neurilemmomas and neurofibromas can often be managed non-operatively, with observation if asymptomatic or causing minimal symptoms. If there is a concern for malignancy or are symptoms causing distress, surgery is the mainstay of intervention. The goal of any surgical treatment is the removal of the tumor without neurological impairment. Removing neurilemmomas without damaging the nerve is easier than in the removal of a neurofibroma due to the fibrous capsule containing neurilemmomas.<xref ref-type="bibr" rid="article-25797.r14">[14]</xref><xref ref-type="bibr" rid="article-25797.r15">[15]</xref><xref ref-type="bibr" rid="article-25797.r16">[16]</xref></p>
        <p>Electrophysiologic monitoring is important during the removal of neurilemmomas. A longitudinal incision is marked over the tumor site, allowing for exposure of normal nerve proximal and distal to the tumor. Using vessel loops, the healthy nerve is wrapped proximal and distal to the tumor, and the nerve is carefully dissected away from the tumor capsule using Metzenbaum scissors. The tumor is generally removed as a solitary mass when possible.<xref ref-type="bibr" rid="article-25797.r17">[17]</xref></p>
      </sec>
      <sec id="article-25797.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Solitary neurofibromas are benign peripheral nerve tumors that also arise from cells of Schwann that more classically involve the skin or subcutaneous tissue. Like neurilemmomas, neurofibromas are very slow-growing tumors but differ in their histology in that they are not encapsulated as neurilemmomas are. Histopathologically compared to neurofibromas, and protein staining is classically limited to peripheral axons in neurilemmomas.<xref ref-type="bibr" rid="article-25797.r7">[7]</xref><xref ref-type="bibr" rid="article-25797.r18">[18]</xref></p>
      </sec>
      <sec id="article-25797.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In a study by Kim et al., patients that underwent surgical removal of neurilemmomas in the brachial plexus who had full strength pre-operatively maintained their normal strength in 88% of cases. 90% of those who had post-operative weakness had strength that was either improved or unchanged from their preoperative examination.<xref ref-type="bibr" rid="article-25797.r17">[17]</xref>&#x000a0;In another series by Young et al., 52% of patients who underwent resection had resolution of their symptoms, with 18% having improved symptoms.<xref ref-type="bibr" rid="article-25797.r19">[19]</xref></p>
      </sec>
      <sec id="article-25797.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Neurilemmomas of the extremities are typically asymptomatic and only create a mass. Sometimes, however, the mass effect of the neoplasm can cause dysfunction of the nerve. While most symptoms are pain in the distribution of the nerve and sensory deficits or paresthesias, neurilemmomas of the anterior nerves of the spinal cord may produce symptoms of weakness and motor dysfunction as well.&#x000a0;</p>
        <p>If excised surgically, neurilemmomas are typically removed without damage to the nerve, as the tumor is derived from the surrounding cells of Schwann and not directly from the nerve axon themselves. That being said, any surgery carries risk. Injury to the nerve itself is uncommon, but always a possibility through traction injuries or disruption of the axon. As with all surgery, wound complications may occur as well. Recurrence is possible, but rare in benign tumors of the nerve sheath.</p>
      </sec>
      <sec id="article-25797.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Neurilemmomas are benign findings, and while they can produce symptoms due to mass effects on surrounding tissues, they generally are not a cause for concern.&#x000a0;If a patient experiences pain or neurologic deficit, disfigurement, bleeding, or if there is suspicion for a developing malignancy, surgery may be indicated. Surgical intervention does yield very favorable outcomes, with some expected risk of associated nerve damage.&#x000a0;</p>
      </sec>
      <sec id="article-25797.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Appropriate management of neurilemmomas requires a cooperative effort of the interdisciplinary healthcare team. Any mass of unknown etiology should be evaluated by an appropriate healthcare professional. First-line providers should have a basic knowledge of benign nerve sheath tumors to order appropriate testing and help patients choose the best course of management. Referral to specialists such as neurologists and surgeons as appropriate will also be critical for the appropriate monitoring of tumors and guiding the patient towards an optimal outcome.</p>
        <p>As always, the cooperation of the entire medical team is critical. Nurses and office staff must be comfortable in their working environment to provide the best possible care, and communication is key to enacting the agreed-upon plan of management. Furthermore, if surgical intervention is required, operating room nurses and staff must be familiar with standard surgical procedures and comfortable with executing the operative plan. [Level 5]</p>
      </sec>
      <sec id="article-25797.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25797&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25797">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nerve-health/neurilemmoma-schwannomas/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25797">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25797/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25797">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25797.s15">
        <fig id="article-25797.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Neurilemmomas Contributed by Donald Davis, MD (Not copyrighted Image)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Screen__Shot__2020-06-16__at__6.25.00__AM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25797.s16">
        <title>References</title>
        <ref id="article-25797.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hilton</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hanemann</surname>
                <given-names>CO</given-names>
              </name>
            </person-group>
            <article-title>Schwannomas and their pathogenesis.</article-title>
            <source>Brain Pathol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-20</page-range>
            <pub-id pub-id-type="pmid">24450866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pilavaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chourmouzi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kiziridou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skordalaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zarampoukas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Drevelengas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review.</article-title>
            <source>Eur J Radiol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>229</fpage>
            <page-range>229-39</page-range>
            <pub-id pub-id-type="pmid">15544900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saeed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gurusinghe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ramsden</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.</article-title>
            <source>Otol Neurotol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-7</page-range>
            <pub-id pub-id-type="pmid">15699726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hegarty</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fischbein</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Jackler</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of "incidental" acoustic neuroma.</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>131</volume>
            <issue>3</issue>
            <fpage>241</fpage>
            <page-range>241-4</page-range>
            <pub-id pub-id-type="pmid">15781765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Propp</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Preston-Martin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Descriptive epidemiology of vestibular schwannomas.</article-title>
            <source>Neuro Oncol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">16443943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stangerup</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cay&#x000e9;-Thomasen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>What is the real incidence of vestibular schwannoma?</article-title>
            <source>Arch Otolaryngol Head Neck Surg</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-20</page-range>
            <pub-id pub-id-type="pmid">14967754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Folpe</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.</article-title>
            <source>Acta Neuropathol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-319</page-range>
            <pub-id pub-id-type="pmid">22327363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Langloss</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Enzinger</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.</article-title>
            <source>Lab Invest</source>
            <year>1983</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-308</page-range>
            <pub-id pub-id-type="pmid">6310227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamabe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hamashima</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Distribution of collagen type IV in soft tissue tumors. An immunohistochemical study.</article-title>
            <source>Cancer</source>
            <year>1986</year>
            <month>Jul</month>
            <day>15</day>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-77</page-range>
            <pub-id pub-id-type="pmid">3521829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawahara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ooi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakanishi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Umeda</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-20</page-range>
            <pub-id pub-id-type="pmid">3124642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.</article-title>
            <source>Am J Pathol</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>159</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-61</page-range>
            <pub-id pub-id-type="pmid">11438454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crist</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Frick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gi</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Magnetic Resonance Imaging Appearance of Schwannomas from Head to Toe: A Pictorial Review.</article-title>
            <source>J Clin Imaging Sci</source>
            <year>2017</year>
            <volume>7</volume>
            <fpage>38</fpage>
            <pub-id pub-id-type="pmid">29114437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skovronsky</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Oberholtzer</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Pathologic classification of peripheral nerve tumors.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-66</page-range>
            <pub-id pub-id-type="pmid">15177315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golan</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Jacques</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Nonneoplastic peripheral nerve tumors.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-30</page-range>
            <pub-id pub-id-type="pmid">15177321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Perrin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guha</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Peripheral nerve tumors: management strategies and molecular insights.</article-title>
            <source>J Neurooncol</source>
            <year>2004</year>
            <season>Aug-Sep</season>
            <volume>69</volume>
            <issue>1-3</issue>
            <fpage>335</fpage>
            <page-range>335-49</page-range>
            <pub-id pub-id-type="pmid">15527099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrugala</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Batchelor</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Peripheral and cranial nerve sheath tumors.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>604</fpage>
            <page-range>604-10</page-range>
            <pub-id pub-id-type="pmid">16155448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Murovic</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tiel</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Kline</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Operative outcomes of 546 Louisiana State University Health Sciences Center peripheral nerve tumors.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-92</page-range>
            <pub-id pub-id-type="pmid">15177317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nascimento</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>1363</fpage>
            <page-range>1363-70</page-range>
            <pub-id pub-id-type="pmid">17721192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25797.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Ingram</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Metcalf-Doetsch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Al Sannaa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Le Loarer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>AJF</given-names>
              </name>
              <name>
                <surname>Slopis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>McCutcheon</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.</article-title>
            <source>J Neurosurg</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>805</fpage>
            <page-range>805-814</page-range>
            <pub-id pub-id-type="pmid">28885122</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
